The Centers for Disease Control and Prevention (CDC) reportedly delayed the publication of its report detailing the benefits of the COVID-19 vaccine at the behest of its acting director. Acting CDC Director Jay Bhattacharya delayed the report because of concerns about its methodology, The Washington Post reported Thursday. The report was focused on the vaccine’s…
Cancer Drug Shortfalls Tied to How BET Inhibitors Hit BRD2 and BRD4 Differently
For more than a decade, BET inhibitors have been touted as one of cancer therapy’s most promising drug classes. The logic was straightforward: many tumors
